
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
Episodes

Thursday Jun 05, 2025
Thursday Jun 05, 2025
In this podcast, Mr. Jean-Philippe Adam, Dr. Mélodie Richard-Laferrière, and Dr. Félix Trudel-Bourgault discuss the AJHP Practice Research Report, “Teleworking by hospital pharmacists: Another step to achieve decarbonization of the healthcare system,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday Jun 04, 2025
Practice Journeys: Meet the Leadership of the Infusion Services Strategy Committee
Wednesday Jun 04, 2025
Wednesday Jun 04, 2025
A new ad hoc committee created as a collaboration between the Sections of Specialty Pharmacy Practitioners, Section of Pharmacy Practice Leaders, Section of Ambulatory Care Practitioners and Section of Inpatient Care Practitioners, the Infusion Services Strategy Committee began its work in August of 2024. Committee Chair, Samantha Bochenek, and Vice Chair, Noah Franz, join us on this podcast onsite at the ASHP Midyear Clinical Meeting to share some of their experiences within health system infusion services and an overview of the Committee’s goals and priority areas.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday Jun 04, 2025
Wednesday Jun 04, 2025
Drug shortages remain a persistent threat to patient care and pharmacy operations, with 270 active shortages recorded in early 2025. In this episode of Hot Topics in Pharmacy, ASHP’s Mike Ganio hosts Erin Fox and April Giles to unpack the latest data, explore the day-to-day realities health systems are facing, and examine the complex challenges shaping the future of medication access.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tuesday Jun 03, 2025
Tuesday Jun 03, 2025
This podcast will provide members with analysis of the Administration’s actions on drug pricing to date, including proposed tariffs and two separate Executive Orders (EOs). We’ll talk through key elements of the EO on Most Favored Nation pricing, how it might intersect with the earlier, more general EO on drug pricing, and what these policy shifts could mean for members. We’ll also discuss how potential tariffs on pharmaceuticals might further complicate the drug pricing picture.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Monday Jun 02, 2025
Monday Jun 02, 2025
In this podcast, we’ve partnered with a data science pharmacist to explore challenges that can arise when implementing artificial intelligence (AI) in pharmacy. We’ll focus on his experience with AI governance, ethical challenges, and key considerations for the everyday pharmacist.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Saturday May 31, 2025
Saturday May 31, 2025
This episode focuses on the operational considerations for the use of in vivo and viral based gene therapies in health-system pharmacies and the appropriate stakeholders. CE for this episode expires on May 31, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday May 30, 2025
Friday May 30, 2025
In this Pharmacy Leadership episode, Ashley Boedecker sits down with the Section of Ambulatory Care Practitioners Awardee Jessica Skelley to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday May 29, 2025
Thursday May 29, 2025
In this episode, members of the ASHP Pharmacy Administration and Leadership Residents’ Collaborative dive into practical strategies for becoming a highly engaged and effective learner as a Pharmacy Administration and Leadership (PAL) resident. Whether you're navigating clinical rotations or administrative responsibilities, this podcast features current PGY1 & PGY2 HSPAL residents and experienced pharmacy leaders sharing tips on fostering curiosity, building relationships, and actively participating in diverse learning environments.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday May 28, 2025
Wednesday May 28, 2025
Learn from experts on treatments for patients with obesity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tuesday May 27, 2025
Tuesday May 27, 2025
In this episode, Julie Dagam sits down with Andrea Roberson to discuss the upcoming session entitled Be Prepared: Frequent Findings and Trusty Tips for Pharmacy Residency Accreditation, and with Michelle Rager to discuss the upcoming session entitled “The Need for Speed”—Efficient and Effective Residency CQI and Reporting. These sessions are part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
